# Ascension Orthopedics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ascension-orthopedics

- Industry: Medical Devices & Equipment
- Headquarters: Austin, US
- Website: www.ascensionortho.com
- Total disclosed funding: $44M
- Latest round: Series E (Jul 7, 2011)
- Investors on record: 1

## About

Ascension Orthopedics develops innovative orthopedic implants and solutions, focusing on improving patient outcomes through advanced technology and design. Their products cater to various orthopedic needs, emphasizing reliability and effectiveness in surgical procedures.Founded in 1992 and headquartered in Austin, US, Ascension Orthopedics specializes in orthopedic solutions. The company underwent a significant transition when it was acquired by Integra LifeSciences Holdings Corporation in September 2011. The current CEO is Guy Mayer, who has experience in leading healthcare organizations and enhancing operational efficiencies. Ascension Orthopedics has successfully concluded a total of four funding deals, with the most recent being a Series E round in which they raised USD 18.66 mn, bringing the total amount raised to USD 18.66 mn and currently valuing the company at USD 98.18 mn.Ascension Orthopedics specializes in designing and manufacturing orthopedic implants and surgical solutions. Their offerings include a range of products aimed at addressing various orthopedic conditions, ensuring that surgical teams have access to advanced tools that support effective patient care. The company caters primarily to healthcare providers and institutions, focusing on delivering high-quality orthopedic solutions that facilitate improved surgical outcomes. Their products are distributed globally, with a presence in key markets such as the United States, Canada, Europe, China, and Australia.Ascension Orthopedics generates revenue through the sale of its orthopedic products, which include specialized implants and surgical devices. The company operates a business-to-business model, supplying its products to hospitals and surgical centers. Transactions are conducted through direct sales to healthcare providers, ensuring timely access to essential orthopedic solutions. Their pricing strategy is competitive within the orthopedic device market, supporting healthcare providers' operational needs and patient care objectives. Revenue streams are further augmented by strategic partnerships and collaborations in the healthcare sector.Ascension Orthopedics is focused on expanding its product offerings with innovative orthopedic implants scheduled for release in the coming years, aiming to enhance surgical options by 2025. The company plans to penetrate new geographic markets, particularly in Southeast Asia and Latin America, targeting to establish a foothold by 2024. The recent funding from the Series E round will be utilized to support these expansion efforts, including product development and market entry strategies, ensuring that Ascension Orthopedics strengthens its global presence and meets diverse orthopedic needs.

## Funding rounds

- Series E, Jul 7, 2011, $19M — Frazier Healthcare Partners
- Series D, Dec 21, 2007, $20M — Frazier Healthcare Partners
- Series C, Oct 21, 2005, $5M — Frazier Healthcare Partners

## Investors

- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series C, Series D, Series E